HK Stock MarketDetailed Quotes
02367 GIANT BIOGENE
- 51.100
- -0.600-1.16%
Trading Oct 16 15:21 CST
52.54BMarket Cap27.12P/E (TTM)
52.600High49.700Low4.58MVolume51.550Open51.700Pre Close233.51MTurnover0.45%Turnover Ratio32.80P/E (Static)1.03BShares58.00052wk High8.03P/B52.54BFloat Cap27.78052wk Low0.97Dividend TTM1.03BShs Float58.000Historical High0.970Dividend LFY5.61%Amplitude23.180Historical Low51.004Avg Price200Lot Size1.90%Div YieldTTM1.90%Div Yield LFY
GIANT BIOGENE Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Current assets | |||||||
| Inventory | 78.96%333.74M | 9.00%200.44M | --186.49M | 105.71%183.9M | 38.26%89.39M | 27.12%64.66M | --50.86M |
| Accounts receivable | 115.25%195.92M | 46.97%102.03M | --91.02M | 5.76%69.42M | 20.39%65.64M | 215.89%54.52M | --17.26M |
| Related party payments receivable | ---- | ---- | ---- | ---- | ---- | -63.72%201.31M | --554.9M |
| Advance deposits and other receivables | 23.78%94.47M | -38.47%53.84M | --76.32M | 216.08%87.5M | 271.07%27.68M | -54.20%7.46M | --16.29M |
| Cash and equivalents | 193.06%4.56B | 88.14%2.5B | --1.56B | -81.26%1.33B | 1,831.19%7.1B | 408.56%367.81M | --72.32M |
| Financial assets at fair value-current assets | 22.57%1.5B | 47.21%1.27B | --1.22B | 456.51%865.97M | -90.20%155.61M | 112.74%1.59B | --746.62M |
| Total current assets | 113.35%6.69B | 62.94%4.14B | --3.13B | -65.90%2.54B | 225.79%7.44B | 56.63%2.28B | --1.46B |
| Non-current assets | |||||||
| Property, plant and equipment | 66.30%928.67M | 35.01%663.47M | --558.42M | 79.13%491.42M | 14.13%274.34M | -7.10%240.36M | --258.72M |
| Investment property | ---- | ---- | ---- | ---- | -7.35%24.17M | --26.09M | ---- |
| Advance payment | -23.35%99.91M | 188.32%117.91M | --130.34M | -41.78%40.9M | 39.93%70.24M | 98.16%50.2M | --25.33M |
| Associated company interest | --10.26M | ---- | ---- | ---- | ---- | ---- | ---- |
| Intangible assets | 9.23%6.57M | 8.98%7.36M | --6.02M | -11.15%6.75M | -13.48%7.6M | -4.06%8.78M | --9.15M |
| Deferred tax assets | -13.33%156K | -6.72%1.11M | --180K | -11.98%1.19M | 9.92%1.35M | -71.10%1.23M | --4.26M |
| Total non-current assets | 47.00%1.09B | 39.55%838M | --743.13M | 37.45%600.49M | 19.04%436.89M | 8.36%367.01M | --338.68M |
| Total assets | 100.63%7.78B | 58.47%4.97B | --3.88B | -60.17%3.14B | 197.17%7.88B | 47.53%2.65B | --1.8B |
| Liabilities | |||||||
| Current liabilities | |||||||
| Accounts payable | 359.28%337.11M | 143.55%133.11M | --73.4M | 131.46%54.65M | -26.09%23.61M | 40.24%31.95M | --22.78M |
| Tax payable | 24.33%97.67M | 55.59%116.72M | --78.56M | 5.14%75.02M | -50.53%71.36M | 17.39%144.23M | --122.87M |
| Dividend payable | ---- | ---- | ---- | ---- | -80.66%367.46M | 378.59%1.9B | --397M |
| Other payables and accrued expenses | 649.06%1.27B | 77.40%241.97M | --168.91M | -97.86%136.4M | 6,679.36%6.36B | 20.73%93.86M | --77.74M |
| Financial lease liabilities-current liabilities | 51.88%1.37M | 77.41%1.56M | --902K | --881K | ---- | ---- | ---- |
| Deferred income-current liabilities | 16.42%1.5M | 0.00%1.5M | --1.29M | 0.20%1.5M | -44.05%1.5M | 65.49%2.68M | --1.62M |
| Total current liabilities | 422.14%1.76B | 88.89%530.61M | --336.24M | -95.90%280.91M | 214.78%6.84B | 247.24%2.17B | --626.05M |
| Net current assets | 76.25%4.93B | 59.71%3.6B | --2.8B | 277.22%2.26B | 442.86%598.28M | -86.76%110.21M | --832.2M |
| Total assets less current liabilities | 70.11%6.02B | 55.48%4.44B | --3.54B | 176.03%2.86B | 116.92%1.04B | -59.24%477.22M | --1.17B |
| Non-current liabilities | |||||||
| Financial lease liabilities-non-current liabilities | -92.80%87K | -31.61%1.17M | --1.21M | --1.71M | ---- | ---- | ---- |
| Deferred tax liability | 517.49%31.2M | 12,474.44%50.68M | --5.05M | -47.73%403K | -37.92%771K | 10,250.00%1.24M | --12K |
| Deferred income-non-current liabilities | 4.58%18.86M | 7.68%19.58M | --18.03M | 3.38%18.18M | -2.16%17.58M | -7.46%17.97M | --19.42M |
| Total non-current liabilities | 106.41%50.15M | 252.03%71.42M | --24.29M | 10.53%20.29M | -4.48%18.36M | -1.13%19.22M | --19.43M |
| Total liabilities | 400.87%1.81B | 99.88%602.03M | --360.53M | -95.61%301.19M | 212.86%6.86B | 239.76%2.19B | --645.49M |
| Total assets less total liabilities | 69.86%5.97B | 54.07%4.37B | --3.52B | 179.01%2.84B | 122.01%1.02B | -60.22%458M | --1.15B |
| Total equity and non-current liabilities | 70.11%6.02B | 55.48%4.44B | --3.54B | 176.03%2.86B | 116.92%1.04B | -59.24%477.22M | --1.17B |
| Equity | |||||||
| Share capital | 3.17%65K | 0.00%63K | --63K | 8.62%63K | --58K | ---- | ---- |
| Other equity instruments | ---- | ---- | ---- | ---- | --23K | ---- | ---- |
| Reserve | 70.05%5.97B | 53.95%4.36B | --3.51B | 178.68%2.83B | 121.99%1.02B | -60.09%458M | --1.15B |
| Shareholders' Equity | 70.05%5.97B | 53.95%4.36B | --3.51B | 178.66%2.83B | 122.01%1.02B | -60.09%458M | --1.15B |
| Non-controlling interest | -29.02%4.72M | 150.21%8.91M | --6.64M | --3.56M | ---- | ---- | --3.75M |
| Total equity | 69.86%5.97B | 54.07%4.37B | --3.52B | 179.01%2.84B | 122.01%1.02B | -60.22%458M | --1.15B |
| Total equity and total liabilities | 100.63%7.78B | 58.47%4.97B | --3.88B | -60.17%3.14B | 197.17%7.88B | 47.53%2.65B | --1.8B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data